Total Payments
$179,175
2024 Payments
$71,908
Companies
17
Transactions
235
Medicare Patients
7,790
Medicare Billing
$6.1M
Payment Breakdown by Category
Other$125,886 (70.3%)
Consulting$27,307 (15.2%)
Travel$17,348 (9.7%)
Food & Beverage$8,570 (4.8%)
Education$64.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125,886 | 37 | 70.3% |
| Consulting Fee | $27,307 | 10 | 15.2% |
| Travel and Lodging | $17,348 | 60 | 9.7% |
| Food and Beverage | $8,570 | 126 | 4.8% |
| Education | $64.42 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $110,907 | 84 | $0 (2024) |
| Astellas Pharma US Inc | $33,514 | 37 | $0 (2024) |
| Genentech USA, Inc. | $15,224 | 38 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $10,778 | 18 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $3,325 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,310 | 19 | $0 (2021) |
| Genentech, Inc. | $732.59 | 10 | $0 (2024) |
| Alcon Laboratories Inc | $369.03 | 3 | $0 (2018) |
| Alimera Sciences, Inc. | $350.88 | 3 | $0 (2024) |
| Allergan Inc. | $148.72 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,908 | 74 | Astellas Pharma US Inc ($31,188) |
| 2023 | $42,422 | 52 | Regeneron Healthcare Solutions, Inc. ($37,426) |
| 2022 | $15,621 | 22 | Regeneron Healthcare Solutions, Inc. ($15,192) |
| 2021 | $9,574 | 19 | Regeneron Healthcare Solutions, Inc. ($7,266) |
| 2020 | $29,458 | 25 | Regeneron Healthcare Solutions, Inc. ($29,458) |
| 2019 | $8,233 | 25 | Genentech USA, Inc. ($4,783) |
| 2018 | $427.84 | 5 | Alcon Laboratories Inc ($128.57) |
| 2017 | $1,530 | 13 | Regeneron Pharmaceuticals, Inc. ($584.74) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $4,344.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,896.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,448.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,434.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $84.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $337.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $122.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $97.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/14/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $186.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $60.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Travel and Lodging | Cash or cash equivalent | $551.65 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Travel and Lodging | Cash or cash equivalent | $235.13 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $107.71 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $346.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $154.44 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,243.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $286.76 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,379 | 21,347 | $6.8M | $2.2M |
| 2022 | 14 | 2,063 | 6,802 | $3.6M | $1.4M |
| 2021 | 12 | 1,870 | 6,193 | $3.3M | $1.4M |
| 2020 | 11 | 1,478 | 4,826 | $2.6M | $1.1M |
Total Patients
7,790
Total Services
39,168
Medicare Billing
$6.1M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 145 | 1,694 | $2.6M | $1.2M | 44.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 27 | 12,360 | $1.7M | $357,478 | 21.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 296 | 1,563 | $635,500 | $160,582 | 25.3% |
| J3490 | Unclassified drugs | Office | 2023 | 34 | 98 | $575,057 | $138,081 | 24.0% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 18 | 693 | $266,040 | $83,410 | 31.4% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 43 | 485 | $242,500 | $75,878 | 31.3% |
| 92134 | Imaging of retina | Office | 2023 | 601 | 2,129 | $217,158 | $70,535 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 374 | 904 | $200,688 | $61,351 | 30.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 170 | 683 | $170,750 | $48,579 | 28.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 235 | 291 | $91,374 | $25,416 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 172 | $54,180 | $16,497 | 30.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 12 | 12 | $34,524 | $10,760 | 31.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 80 | 80 | $22,526 | $9,371 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $17,094 | $4,948 | 28.9% |
| 92250 | Photography of the retina | Office | 2023 | 111 | 113 | $18,532 | $3,252 | 17.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 23 | 28 | $6,468 | $1,062 | 16.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 111 | 1,443 | $2.2M | $1.0M | 46.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 261 | 1,243 | $480,190 | $121,393 | 25.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 12 | 268 | $171,520 | $59,757 | 34.8% |
| 92134 | Imaging of retina | Office | 2022 | 542 | 1,711 | $174,522 | $56,730 | 32.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 165 | 718 | $179,500 | $51,536 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 296 | 687 | $152,514 | $46,608 | 30.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 201 | 242 | $75,988 | $22,909 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 214 | $67,410 | $20,708 | 30.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 92 | 92 | $20,700 | $9,818 | 47.4% |
About Dr. Christopher Aderman, M.D
Dr. Christopher Aderman, M.D is a Ophthalmology healthcare provider based in Troutdale, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1912260381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Aderman, M.D has received a total of $179,175 in payments from pharmaceutical and medical device companies, with $71,908 received in 2024. These payments were reported across 235 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,886).
As a Medicare-enrolled provider, Aderman has provided services to 7,790 Medicare beneficiaries, totaling 39,168 services with total Medicare billing of $6.1M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Troutdale, OR
- Active Since 06/20/2012
- Last Updated 02/20/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1912260381
Products in Payments
- EYLEA (Biological) $69,281
- EYLEA HD (Biological) $51,479
- Izervay (Drug) $33,138
- Vabysmo (Drug) $8,136
- Lucentis (Biological) $7,250
- BEOVU (Drug) $2,507
- Syfovre (Drug) $1,511
- Constellation (Device) $369.03
- VABYSMO (Drug) $340.23
- EYLEA AFLIBERCEPT INJECTION (Biological) $339.16
- OZURDEX (Drug) $279.61
- Susvimo (Drug) $178.95
- YUTIQ (Drug) $154.44
- STELLARIS PC (Device) $121.43
- Iluvien (Drug) $111.44
- ILUVIEN (Drug) $85.00
- SUSVIMO (Drug) $84.28
- EVA Ophthalmic Surgical System (Device) $79.66
- ARGOS (Device) $31.50
- FLAREX (Drug) $21.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.